ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,100Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 783

$563K Total Retail Price of All Prescriptions

Rank: 215 out of 783

364 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 11,198 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 539 472 1 4
FUROSEMIDE 463 414 2 7
HYDROCODONE-ACETAMINOPHEN 454 374 S3 3 2
LEVOTHYROXINE SODIUM 436 369 4 1
SIMVASTATIN 425 362 5 3
OMEPRAZOLE 414 340 6 6
AMLODIPINE BESYLATE 339 305 7 5
WARFARIN SODIUM 333 307 8 10
POTASSIUM CHLORIDE 306 280 9 16
CITALOPRAM HBR 303 283 10 19
HYDROCHLOROTHIAZIDE 295 249 11 12
MELOXICAM 220 188 12 37
METOPROLOL SUCCINATE 220 208 12 13
ZOLPIDEM TARTRATE 192 134 14 23
METFORMIN HCL 188 157 15 8
LOVASTATIN 184 161 16 58
DONEPEZIL HCL 173 173 17 24
ATENOLOL 158 136 18 17
GABAPENTIN 144 89 19 15
SPIRONOLACTONE 137 124 20 57
MIRTAZAPINE 130 118 21 52
SERTRALINE HCL 128 96 22 22
METOPROLOL TARTRATE 119 119 23 9
ISOSORBIDE MONONITRATE ER 117 115 24 40
TRAMADOL HCL-ACETAMINOPHEN 113 92 25 167
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 96 26 33
FENTANYL 111 110 S2 27 65
DIGOXIN 110 97 28 61
CEPHALEXIN 106 90 29 70
ALLOPURINOL 102 65 30 31
TAMSULOSIN HCL 101 89 31 26
CLOPIDOGREL 89 89 32 29
TRAMADOL HCL 86 81 33 20
AZITHROMYCIN 82 65 34 41
GLIMEPIRIDE 81 81 35 34
PANTOPRAZOLE SODIUM 80 68 36 30
PLAVIX 79 79 37 51
ATORVASTATIN CALCIUM 77 69 38 11
CRESTOR 74 74 39 27
CLONIDINE HCL 74 73 39 60
PREDNISONE 71 66 41 36
NAMENDA 71 71 41 32
LOSARTAN POTASSIUM 70 46 43 18
FAMOTIDINE 70 56 43 55
METFORMIN HCL ER 69 69 45 64
AMOXICILLIN 64 59 46 116
FLUOXETINE HCL 63 44 47 45
PROMETHAZINE HCL 60 44 R 48 97
CYCLOBENZAPRINE HCL 60 42 R 48 63
GLIPIZIDE 58 49 50 71
AMITRIPTYLINE HCL 58 44 R 50 77
QUETIAPINE FUMARATE 57 49 52 79
POLYETHYLENE GLYCOL 3350 57 55 52 43
LOSARTAN-HYDROCHLOROTHIAZIDE 56 52 54 53
RISPERIDONE 55 55 55 67
ESCITALOPRAM OXALATE 55 52 55 54
CARVEDILOL 53 50 57 21
LEVOFLOXACIN 52 43 58 75
KLOR-CON 10 52 48 58 102
NIASPAN 52 52 58 140
TRIAMTERENE-HCTZ 51 51 61 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.